MLL-AF4, however, is essential for leukemic maintenance [12] and this, combined with the fact that t(4;11) leukemias have very few cooperating mutations [10], suggests that a detailed understanding of the function of MLL-AF4 may aid in the design of targeted therapies. This evidence concerns the gene KMT2A and leukemia.